Cigna

CI

Market cap $79.2B

Overview Fund Activity

296.59 USD

+2.38

0.81%

At close Updated Sep 17, 4:00 PM EDT

Pre-market

After hours

296.59

0.00

0%

1 day

0.81%

5 days

-2.59%

1 month

-0.58%

3 months

-5.09%

6 months

-6.38%

Year to date

8.05%

1 year

-16.74%

5 years

75.5%

10 years

107.77%

About: Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

Employees: 73,500

Healthcare Healthcare Plans

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

60% more first-time investments, than exits

New positions opened: 165 | Existing positions closed: 103

51% more call options, than puts

Call options by funds: $1.56B | Put options by funds: $1.03B

11% more repeat investments, than reductions

Existing positions increased: 645 | Existing positions reduced: 580

2% more funds holding

Funds holding: 1,670 [Q1] → 1,701 (+31) [Q2]

0.48% more ownership

Funds ownership: 87.58% [Q1] → 88.05% (+0.48%) [Q2]

1% less capital invested

Capital invested by funds: $78.1B [Q1] → $77.6B (-$506M) [Q2]

39% less funds holding in top 10

Funds holding in top 10: 38 [Q1] → 23 (-15) [Q2]

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$340

15% upside

Avg. target

$364

23% upside

High target

$383

29% upside

6 analyst ratings

5 positive

83%

1 neutral

17%

0 negative

0%

Barclays Andrew Mok	$383	Overweight Maintained	4 Sep 2025
Cantor Fitzgerald Sarah James	$365	Overweight Reiterated	26 Aug 2025
Baird Michael Ha	$374	Outperform Maintained	14 Aug 2025
Wells Fargo Stephen Baxter	$340	Equal-Weight Maintained	14 Aug 2025
Guggenheim Jason Cassorla	$350	Buy Maintained	4 Aug 2025
RBC Capital Ben Hendrix	$371	Outperform Reiterated	26 Jun 2025

See Analyst Rankings

Financial journalist opinion

Based on 7 articles about CI published over the past 30 days

Rate of employers covering weight-loss drugs is flat, Cigna says

Cigna said on Wednesday the percentage of employers paying for obesity drugs has remained flat year-over-year, though the health insurer still sees an uptick in demand for the wildly popular treatments.

Rate of employers covering weight-loss drugs is flat, Cigna says

The Cigna Group Announces Appearance at the Morgan Stanley 23rd Annual Global Healthcare Conference

BLOOMFIELD, Conn. , Sept. 10, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and COO of The Cigna Group, and Ann Dennison, EVP and CFO of the Cigna Group will present at the Morgan Stanley 23rd Annual Global Healthcare Conference today, September 10, 2025, in New York, NY.

The Cigna Group Announces Appearance at the Morgan Stanley 23rd Annual Global Healthcare Conference

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of “bbb+” (Good) to The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI] new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratings) is stable. (Please see below for a detailed list of the Long-Term IRs.) Concurrently, AM Best has withdrawn the ra.

AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Cigna Group's CI Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions, a specialty pharmacy management company.

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Cigna's Evernorth invests $3.5 billion in Shields

Cigna Group's unit Evernorth Health on Tuesday said it is investing $3.5 billion in specialty pharmacy company Shields Health.

Cigna's Evernorth invests $3.5 billion in Shields

Evernorth Health Services Announces Investment in Shields Health Solutions

Investment Further Enhances Evernorth's Participation in Growing Market for Specialty Medicine BLOOMFIELD, Conn. , Sept. 2, 2025 /PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE: CI), today announced a $3.5 billion investment in Shields Health Solutions ("Shields" or the "Company"), a leading specialty pharmacy management company.

Evernorth Health Services Announces Investment in Shields Health Solutions

Cigna: Market Pessimism Creates Value Opportunity

Cigna's stock drop after Q2 2025 is overdone; shares now trade at a 15% discount to their 5-year average, creating a compelling entry point. Despite mixed Q2 results and lower profit growth forecasts, my DCF model supports a fair value of $315 per share, implying 8.5% upside. Aggressive share buybacks and steady dividend growth enhance shareholder returns, while Cigna maintains strong cash flows and manageable debt.

Cigna: Market Pessimism Creates Value Opportunity

CNBC Television

Gill: We're at a real inflection point for healthcare

Lisa Gill, JP Morgan healthcare analyst, on “Worldwide Exchange,” says healthcare is at an inflection point, with UnitedHealth poised for long-term gains as big investors bet on a turnaround.

Gill: We're at a real inflection point for healthcare

Cigna: Looks More Interesting Here Than UnitedHealth Group

Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent earnings were strong, guidance was affirmed, and valuation is attractive, with Wall Street seeing up to 35% upside potential. Risks remain from medical inflation and PBM regulatory scrutiny, but Cigna's business mix provides more pricing power and operational flexibility than UNH.

Cigna: Looks More Interesting Here Than UnitedHealth Group

See News Rankings

Charts implemented using Lightweight Charts™